Cargando…

Reducing Gadolinium Exposure in Patients Undergoing Monitoring for Meningiomas

Background Due to the non-malignant and slow-growing nature of many meningiomas, surveillance with serial magnetic resonance imaging (MRI) serves as an acceptable management plan. However, repeated imaging with gold-standard contrast-based studies may lead to contrast-associated adverse effects. Non...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathraju, Srikar, Johnson, Kristen, Cicalese, Kyle V, Opalak, Charles F, Broaddus, William C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180544/
https://www.ncbi.nlm.nih.gov/pubmed/37187666
http://dx.doi.org/10.7759/cureus.37492
_version_ 1785041360055697408
author Sathraju, Srikar
Johnson, Kristen
Cicalese, Kyle V
Opalak, Charles F
Broaddus, William C
author_facet Sathraju, Srikar
Johnson, Kristen
Cicalese, Kyle V
Opalak, Charles F
Broaddus, William C
author_sort Sathraju, Srikar
collection PubMed
description Background Due to the non-malignant and slow-growing nature of many meningiomas, surveillance with serial magnetic resonance imaging (MRI) serves as an acceptable management plan. However, repeated imaging with gold-standard contrast-based studies may lead to contrast-associated adverse effects. Non-gadolinium T2 sequences may serve as a suitable alternative without the risk of adverse effects of contrast. Thus, this study sought to investigate the agreement between post-contrast T1 and non-gadolinium T2 MRI sequences in the measurement of meningioma growth. Methodology The Virginia Commonwealth University School of Medicine (VCU SOM) brain tumor database was used to create a cohort of meningioma patients and determine the number of patients who had T1 post-contrast imaging accompanied by readily measurable imaging from either T2 fast spin echo (FSE) or T2 fluid-attenuated inversion recovery (FLAIR) sequences. Measurements of the largest axial and perpendicular diameters of each tumor were conducted by two independent observers using T1 post-contrast, T2 FSE, and T2 FLAIR imaging series. Lin’s concordance correlation coefficient (CCC) was calculated to assess inter-rater reliability between observers and agreement between measurements of tumor diameter among the different imaging sequences. Results In total, 33 patients (average age = 72.1 ± 12.9 years, 90% female) with meningiomas were extracted from our database, with 22 (66.7%) undergoing T1 post-contrast imaging accompanied with readily measurable imaging from T2 FSE and/or T2 FLAIR sequences. The inter-rater reliability between the measurements of T1 axial and perpendicular diameters was 0.96 (95% confidence interval (CI) = 0.92-0.98) and 0.92 (95% CI = 0.83-0.97), respectively. The inter-rater reliability between the measurements of T2 axial perpendicular diameters was 0.93 (95% = CI 0.92-0.97) and 0.89 (95% CI = 0.74-0.95), respectively. The agreements between the measurement of T1 and T2 FSE axial diameter by each observer were 0.97 (95% CI = 0.93-0.98) and 0.92 (95% CI = 0.81-0.97). The agreements between the measurements of T1 and T2 FSE perpendicular diameter measurements by each observer were 0.98 (95% CI = 0.95-0.99) and 0.88 (95% CI = 0.73-0.95). Conclusions Two-thirds of our patients had meningiomas that were readily measurable on either T2 FSE or T2 FLAIR sequences. Additionally, there was excellent inter-rater reliability between the observers in our study as well as an agreement between individual measurements of T1 post-contrast and T2 FSE tumor diameters. These findings suggest that T2 FSE may serve as a safe and similarly effective surveillance method for the long-term management of meningioma patients.
format Online
Article
Text
id pubmed-10180544
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101805442023-05-13 Reducing Gadolinium Exposure in Patients Undergoing Monitoring for Meningiomas Sathraju, Srikar Johnson, Kristen Cicalese, Kyle V Opalak, Charles F Broaddus, William C Cureus Radiology Background Due to the non-malignant and slow-growing nature of many meningiomas, surveillance with serial magnetic resonance imaging (MRI) serves as an acceptable management plan. However, repeated imaging with gold-standard contrast-based studies may lead to contrast-associated adverse effects. Non-gadolinium T2 sequences may serve as a suitable alternative without the risk of adverse effects of contrast. Thus, this study sought to investigate the agreement between post-contrast T1 and non-gadolinium T2 MRI sequences in the measurement of meningioma growth. Methodology The Virginia Commonwealth University School of Medicine (VCU SOM) brain tumor database was used to create a cohort of meningioma patients and determine the number of patients who had T1 post-contrast imaging accompanied by readily measurable imaging from either T2 fast spin echo (FSE) or T2 fluid-attenuated inversion recovery (FLAIR) sequences. Measurements of the largest axial and perpendicular diameters of each tumor were conducted by two independent observers using T1 post-contrast, T2 FSE, and T2 FLAIR imaging series. Lin’s concordance correlation coefficient (CCC) was calculated to assess inter-rater reliability between observers and agreement between measurements of tumor diameter among the different imaging sequences. Results In total, 33 patients (average age = 72.1 ± 12.9 years, 90% female) with meningiomas were extracted from our database, with 22 (66.7%) undergoing T1 post-contrast imaging accompanied with readily measurable imaging from T2 FSE and/or T2 FLAIR sequences. The inter-rater reliability between the measurements of T1 axial and perpendicular diameters was 0.96 (95% confidence interval (CI) = 0.92-0.98) and 0.92 (95% CI = 0.83-0.97), respectively. The inter-rater reliability between the measurements of T2 axial perpendicular diameters was 0.93 (95% = CI 0.92-0.97) and 0.89 (95% CI = 0.74-0.95), respectively. The agreements between the measurement of T1 and T2 FSE axial diameter by each observer were 0.97 (95% CI = 0.93-0.98) and 0.92 (95% CI = 0.81-0.97). The agreements between the measurements of T1 and T2 FSE perpendicular diameter measurements by each observer were 0.98 (95% CI = 0.95-0.99) and 0.88 (95% CI = 0.73-0.95). Conclusions Two-thirds of our patients had meningiomas that were readily measurable on either T2 FSE or T2 FLAIR sequences. Additionally, there was excellent inter-rater reliability between the observers in our study as well as an agreement between individual measurements of T1 post-contrast and T2 FSE tumor diameters. These findings suggest that T2 FSE may serve as a safe and similarly effective surveillance method for the long-term management of meningioma patients. Cureus 2023-04-12 /pmc/articles/PMC10180544/ /pubmed/37187666 http://dx.doi.org/10.7759/cureus.37492 Text en Copyright © 2023, Sathraju et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiology
Sathraju, Srikar
Johnson, Kristen
Cicalese, Kyle V
Opalak, Charles F
Broaddus, William C
Reducing Gadolinium Exposure in Patients Undergoing Monitoring for Meningiomas
title Reducing Gadolinium Exposure in Patients Undergoing Monitoring for Meningiomas
title_full Reducing Gadolinium Exposure in Patients Undergoing Monitoring for Meningiomas
title_fullStr Reducing Gadolinium Exposure in Patients Undergoing Monitoring for Meningiomas
title_full_unstemmed Reducing Gadolinium Exposure in Patients Undergoing Monitoring for Meningiomas
title_short Reducing Gadolinium Exposure in Patients Undergoing Monitoring for Meningiomas
title_sort reducing gadolinium exposure in patients undergoing monitoring for meningiomas
topic Radiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180544/
https://www.ncbi.nlm.nih.gov/pubmed/37187666
http://dx.doi.org/10.7759/cureus.37492
work_keys_str_mv AT sathrajusrikar reducinggadoliniumexposureinpatientsundergoingmonitoringformeningiomas
AT johnsonkristen reducinggadoliniumexposureinpatientsundergoingmonitoringformeningiomas
AT cicalesekylev reducinggadoliniumexposureinpatientsundergoingmonitoringformeningiomas
AT opalakcharlesf reducinggadoliniumexposureinpatientsundergoingmonitoringformeningiomas
AT broadduswilliamc reducinggadoliniumexposureinpatientsundergoingmonitoringformeningiomas